Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Zenith TX2® Post-market Approval Study

ClinicalTrials.gov ID: NCT00813358

Public ClinicalTrials.gov record NCT00813358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Zenith TX2® TAA Endovascular Graft Post-approval Study

Study identification

NCT ID
NCT00813358
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Cook Research Incorporated
Industry
Enrollment
115 participants

Conditions and interventions

Interventions

  • Zenith TX2® TAA Endovascular Graft Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2009
Primary completion
Feb 13, 2020
Completion
Mar 22, 2020
Last update posted
Jun 3, 2021

2009 – 2020

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Kaiser Permanente San Francisco California 94115
University of Denver Colorado Aurora Colorado 80045
University of Florida Gainesville Florida 32610
Tampa General Hospital Tampa Florida 33601
Heart Care Midwest Peoria Illinois 61614
Iowa Heart Center West Des Moines Iowa 50266
University of Massachusetts Worcester Massachusetts 01655
University of Michigan Hospital Ann Arbor Michigan 48109
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Cooper University Hospital Camden New Jersey 08103
Hackensack University Medical Center Hackensack New Jersey 07601
New York Hospital of Queens Flushing New York 11355
North Shore University Hospital Manhasset New York 11030
New York University New York New York 10016
Strong Memorial Hospital Rochester New York 14642
Montefiore Medical Center The Bronx New York 10467
University of North Carolina Chapel Hill North Carolina 27599
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Allegheny General Hospital Pittsburgh Pennsylvania 15212
DFW Vascular Group Dallas Texas 75208
Baylor University Medical Center at Dallas Dallas Texas 75226
The Heart Hospital Baylor Plano Plano Texas 75093
University of Virginia Medical Center Charlottesville Virginia 22908
Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00813358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00813358 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →